Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Apr 3;15(4):596.
doi: 10.3390/life15040596.

Comparative Analysis of the ELISIO-HX and Xevonta-Hi Dialyzers in Standard Hemodialysis

Affiliations

Comparative Analysis of the ELISIO-HX and Xevonta-Hi Dialyzers in Standard Hemodialysis

Blanca Villacorta Linaza et al. Life (Basel). .

Abstract

As chronic kidney disease (CKD) prevalence rises, optimizing hemodialysis remains essential. While online hemodiafiltration (OL-HDF) is the gold standard, expanded hemodialysis (HDx), i.e., using high-performance dialyzers in standard hemodialysis, remains the most common clinical practice. Medium cutoff (MCO) membranes aim to enhance middle-molecule removal while preserving protein selectivity, although most studies evaluate them in OL-HDF. To this end, this study aims to compare the Xevonta-Hi (B. Braun), a high-flux (HF) polysulfone dialyzer, and the ELISIO-HX (Nipro), an MCO polyethersulfone dialyzer, in standard hemodialysis. In a prospective, observational study, seven stable patients sequentially received treatment with each dialyzer over four weeks. Pre- and post-dialysis levels of small and middle uremic molecules and inflammatory markers-including procalcitonin, prolactin, serum amyloid A, placental growth factor, interleukin-6, haptoglobin, ceruloplasmin, transferrin, prealbumin, and C-reactive protein-were measured. Both dialyzers demonstrated excellent clearance of small and middle molecules, with no significant differences in efficacy. Albumin and total protein losses remained minimal. Moderate reductions in serum amyloid A, placental growth factor, and interleukin-6 were observed, while no significant reductions occurred in the remaining inflammatory markers. These findings support the safety and effectiveness of both MCO and HF dialyzers in standard hemodialysis.

Keywords: expanded hemodialysis (HDx); high-flux dialyzers; inflammatory markers; medium cutoff (MCO) membranes; standard hemodialysis; uremic toxin clearance.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Schematic representation of the study design.
Figure 2
Figure 2
Reduction ratios (RRs%) of small and middle molecules. Small molecules (molecular weight < 500 Da): urea (60 Da), creatinine (113 Da), phosphorus (30 Da), potassium (39 Da), sodium (23 Da), and calcium (40 Da). Middle molecules (molecular weight 500 Da–60 kDa): β2-microglobulin (12 kDa), parathyroid hormone (PTH) (9.4 kDa), procalcitonin (13 kDa), and prolactin (23 kDa). Comparisons of RRs% between dialyzers were made using the Mann–Whitney U test for unpaired samples (95% Confidence Interval).
Figure 3
Figure 3
Reduction ratios (RRs%) of inflammatory markers. Inflammatory markers: transferrin, ceruloplasmin, haptoglobin, prealbumin, C-reactive protein, interleukin-6, placental growth factor (PLGF), and serum amyloid A. Comparisons of RRs% between dialyzers were made using the Mann–Whitney U test for unpaired samples (95% Confidence Interval).

References

    1. Francis A., Harhay M.N., Ong A.C.M., Tummalapalli S.L., Fogo A.B., Fliser D., Roy-Chaudhury P., Fontana M., Nangaku M., Wanner C., et al. Chronic kidney disease and the global public health agenda: An international consensus. Nat. Rev. Nephrol. 2024;20:473–485. - PubMed
    1. Bowry S.K., Chazot C. The scientific principles and technological determinants of haemodialysis membranes. Clin. Kidney J. 2021;14:i5–i16. doi: 10.1093/ckj/sfab184. - DOI - PMC - PubMed
    1. Basile C., Davenport A., Mitra S., Pal A., Stamatialis D., Chrysochou C., Kirmizis D. Frontiers in hemodialysis: Innovations and technological advances. Artif. Organs. 2021;45:175–182. doi: 10.1111/aor.13798. - DOI - PubMed
    1. Nazari S., Abdelrasoul A. Impact of membrane modification and surface immobilization techniques on the hemocompatibility of hemodialysis membranes: A critical review. Membranes. 2022;12:1063. doi: 10.3390/membranes12111063. - DOI - PMC - PubMed
    1. Blankestijn P.J., Vernooij R.W.M., Hockham C., Strippoli G.F., Canaud B., Hegbrant J., Barth C., Covic A., Cromm K., Cucui A., et al. Effect of hemodiafiltration or hemodialysis on mortality in kidney failure. N. Engl. J. Med. 2023;389:700–709. - PubMed

LinkOut - more resources